TABLE 4.
Prevalence of diabetes mellitus in people living with human immunodeficiency virus.
| Author, year | Country | Main outcome variable | Prevalence |
Sample size | Study design | |
|---|---|---|---|---|---|---|
| Cases (PLHIV) | Controls (HIV−ve) | |||||
| Chhoun et al.,11 2017 | Cambodia | Diabetes mellitus | 8.8% | - | 510 | Cross-sectional |
| Machingura et al.,18 2017 | Zimbabwe | Diabetes mellitus | 8.3% | - | 60 | Cross-sectional |
| Maciel et al.,7 2018 | Brazil | Diabetes mellitus | 22.6% | 28.4% | 416 | Cross-sectional |
| Magodoro et al.,12 2016 | Zimbabwe | Type 2 diabetes mellitus | 2.1% | - | 1033 | Cross-sectional |
| Rücker et al.,8 2018 | Malawi | Diabetes mellitus | 5.0% – 13.2% | 1.7% – 4.2% | 735 | Cross-sectional |
| Smit et al.,10 2017 | Italy United States of America |
Diabetes mellitus | 9.0% in 2015 and 27.0% in 2035 12.0% in 2015 and 23.0% in 2035 |
- | 7469 3748 |
Modelling |
| Smit et al.,9 2018 | Zimbabwe | Diabetes mellitus | 1.0% | 0.4% | Population-based | Modelling |
| Lorenc et al.,15 2014 | U.K | Diabetes mellitus | 11.2% | - | 285 | Retrospective |
| Galant et al.,14 2017 | United States of America | Diabetes mellitus | 11% – 37% | - | 64 398 | Retrospective |
| Ruzicka et al.,16 2018 | Japan | Diabetes mellitus | 26.8 | - | 1445 | Retrospective |
| Serrao et al.,17 2018 | Portugal | Diabetes mellitus | 13.5% | - | 401 | Cross-sectional |